Anti-interferon alpha antibodies and autoantibodies in patients with Beh double dagger et's disease uveitis treated with recombinant human interferon alpha-2a
Tarih
2015Yazar
Araz-Ersan, Bilge
Gül, Ahmet
Aydinoglu-Candan, Ozlem
Tugal-Tutkun, Ilknur
Badur, Selim
Üst veri
Tüm öğe kaydını gösterÖzet
Recombinant human (rh) interferon alpha2a (IFN-alpha 2a) therapy is successfully used for the treatment of Beh double dagger et's disease (BD) uveitis refractory to conventional immunosuppressive treatment.
Koleksiyonlar
- Makale [92796]